OpenURL Connection Search

Select item for more details and to access through your institution.

Endothelin Receptor Antagonists in Kidney Disease.
Published in:
International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3427, doi. 10.3390/ijms24043427
By:
- Martínez-Díaz, Irene;
- Martos, Nerea;
- Llorens-Cebrià, Carmen;
- Álvarez, Francisco J.;
- Bedard, Patricia W.;
- Vergara, Ander;
- Jacobs-Cachá, Conxita;
- Soler, Maria José
Publication type:
Article
Enhanced Cardiorenal Protective Effects of Combining SGLT2 Inhibition, Endothelin Receptor Antagonism and RAS Blockade in Type 2 Diabetic Mice.
Published in:
International Journal of Molecular Sciences, 2022, v. 23, n. 21, p. 12823, doi. 10.3390/ijms232112823
By:
- Vergara, Ander;
- Jacobs-Cacha, Conxita;
- Llorens-Cebria, Carmen;
- Ortiz, Alberto;
- Martinez-Diaz, Irene;
- Martos, Nerea;
- Dominguez-Báez, Pamela;
- Van den Bosch, Mireia Molina;
- Bermejo, Sheila;
- Pieper, Michael Paul;
- Benito, Begoña;
- Soler, Maria Jose
Publication type:
Article
The membrane-associated protein 17 (MAP17) is up-regulated in response to empagliflozin on top of RAS blockade in experimental diabetic nephr.
Published in:
Clinical Science, 2023, v. 137, n. 1, p. 87, doi. 10.1042/CS20220447
By:
- Vergara, Ander;
- Llorens-Cebrià, Carmen;
- Martos, Nerea;
- Martínez-Díaz, Irene;
- Stein, Frank;
- Domínguez-Báez, Pamela;
- den Bosch, Mireia Molina-Van;
- Rettel, Mandy;
- Benito, Begoña;
- Bermejo, Sheila;
- Pieper, Michael Paul;
- Jacobs-Cachá, Conxita;
- Soler, Maria José
Publication type:
Article
SGLT2i and GLP1-RA exert additive cardiorenal protection with a RAS blocker in uninephrectomized db/db mice.
Published in:
Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1415879
By:
- Martos-Guillami, Nerea;
- Vergara, Ander;
- Llorens-Cebrià, Carmen;
- Enam Motto, Aku;
- Martínez-Díaz, Irene;
- Gonçalves, Francisco;
- Garcias-Ramis, Maria Magdalena;
- Allo-Urzainqui, Estibaliz;
- Narváez, Alonso;
- Bermejo, Sheila;
- Muñoz, Vicent;
- León-Román, Juan;
- Ferrer-Costa, Roser;
- Jacobs-Cachá, Conxita;
- Vilardell-Vilà, Jordi;
- Soler, María José
Publication type:
Article

Found: 4

Endothelin Receptor Antagonists in Kidney Disease.

Enhanced Cardiorenal Protective Effects of Combining SGLT2 Inhibition, Endothelin Receptor Antagonism and RAS Blockade in Type 2 Diabetic Mice.

The membrane-associated protein 17 (MAP17) is up-regulated in response to empagliflozin on top of RAS blockade in experimental diabetic nephr.

SGLT2i and GLP1-RA exert additive cardiorenal protection with a RAS blocker in uninephrectomized db/db mice.